Document is current
Any future updates will be listed below
-
Authors
Ramsey, Mitchell L. https://orcid.org/0000-0002-6430-1924
Tomlinson, Jewel
Pearlman, Rachel https://orcid.org/0000-0002-9293-5860
Abushahin, Laith https://orcid.org/0000-0001-5155-1185
Aeilts, Amber https://orcid.org/0000-0001-8907-7853
Chen, Hui-Zi https://orcid.org/0000-0003-3744-883X
Chen, Yan
Compton, Ashley
Elkhatib, Rifat
Geiger, Levi
Hays, John https://orcid.org/0000-0003-3140-8677
Jeter, Joanne https://orcid.org/0000-0001-6156-0798
Jin, Ning https://orcid.org/0000-0002-6689-4671
Malalur, Pannaga https://orcid.org/0000-0002-9222-4321
Roychowdhury, Sameek https://orcid.org/0000-0002-8297-3038
Ruple, Jessica
Prebish, Jennifer
Stanich, Peter P. https://orcid.org/0000-0002-6844-640X
Hampel, Heather https://orcid.org/0000-0001-7558-9794
- License Information
-
More Information
Article History
Received: 5 February 2022
Accepted: 29 May 2022
First Online: 17 June 2022
Declarations
:
: PPS receives research support from Emtora Biosciences, Freenome Holdings, Janssen Pharmaceuticals Inc., Pfizer Inc. and the PTEN Research foundation. HH is on the scientific advisory boards for Invitae, Promega, and Genome Medical and has stock/stock options in Genome Medical and GI OnDemand. The remaining authors declare no conflict of interest related to this research.
: This project was reviewed and approved by The Ohio State University Institutional Review Board (protocol 2021E0849).
: Given the retrospective nature of this study and minimal risk of reporting aggregate data, a waiver of informed consent was granted by the Institutional Review Board.
